Interpace Biosciences®, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Investments in Marketable Securities (Tables)

Investments in Marketable Securities (Tables)

12 Months Ended

Dec. 31, 2014

Investments, Debt and Equity Securities [Abstract]

Investments Classified by Contractual Maturity Date [Table Text Block]

At December 31, 2014 and 2013, held-to-maturity investments included:



			Maturing						Maturing
	December 31, 2014		within 1 year		after 1 year through 3 years		December 31, 2013		within 1 year		after 1 year through 3 years
Cash/money market funds	$	204	$	204	$	—	$	116	$	116	$	—
US Treasury securities	1,070		105		965		1,730		1,360		370
Government agency securities	317		225		92		382		382		—
Total	$	1,591	$	534	$	1,057	$	2,228	$	1,858	$	370

Held-to-maturity Securities [Table Text Block]

At December 31, 2014 and December 31, 2013, held-to-maturity investments were recorded in the following accounts:



	December 31, 2014		December 31, 2013
Other current assets	$	534	$	1,858
Other long-term assets	1,057		370
Total	$	1,591	$	2,228

- Definition

Tabular disclosure of all investments in certain debt and equity securities for which the entity has the positive intent and ability to hold until maturity.

+ References + Details